Advancements in cancer diagnosis and treatment have significantly improved survival rates, leading to a growing number of young cancer survivors. This demographic shift brings unique challenges as these individuals navigate life post-treatment, facing physical, emotional, and social upheavals. The
Breast Cancer Awareness Month has highlighted a pressing health crisis among Indian women, particularly those aged 55 to 64. A recent report by Healthians reveals that 16% of women in this demographic are affected by breast cancer. This alarming statistic underscores the urgent need for awareness,
The gene therapy sector, once a beacon of hope for revolutionary treatments, has seen a significant slowdown in investment post the COVID-19 pandemic. This downturn follows a period of unprecedented financial influx during the pandemic years, raising questions about the future of this promising
Recent advancements in medical technologies have often led to breakthroughs that were once considered unattainable, and the field of orthopedic surgery is no exception. Researchers from Cincinnati Children’s Hospital and the University of Cincinnati (UC) have developed an innovative 3D-printed s
Fujifilm Diosynth Biotechnologies, a leading CDMO in the field of biologics, vaccines, advanced therapies, and oncolytic viruses, has embarked on the initial phase of a massive expansion project at their facility in Hillerød, Denmark. By adding six mammalian cell bioreactors to the existing
October 2024 saw a surge in biotech investments, with notable contributions from companies across North America, Europe, and the Asia-Pacific regions. Major players like Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics secured substantial funding, reflecting the growing
In today's rapidly evolving field of biomanufacturing, traditional methods often fall short of the rigorous demands for real-time data and consistent product quality. Laser Force Cytology (LFC) has emerged as an innovative, label-free technology that offers a transformative approach to
The global brain-computer interface (BCI) market is expected to grow from USD $2.1 million in 2022 to USD $9.4 million by 2032, with a growth rate of 16.7% from 2023 to 2032. This exciting area of research and development can create a direct communication link between the human brain and devices
Novo Nordisk recently announced its intention to seek regulatory approval for the use of semaglutide, the active ingredient in its profitable weight loss drug, for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). This decision came after a Phase 3 clinical trial yielded
Neurogene, a trailblazer in the gene therapy field concentrating on rare neurological diseases, has successfully clinched $200 million through a private funding deal designed to extend its financial runway until late 2027. This financing structure, recognized as a PIPE financing (Private Investment
